ADAR1 Capital Management’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
1,759,295
+1,128,892
+179% +$5.38M 0.48% 51
2026
Q1
$3.75M Buy
630,403
+68,338
+12% +$413K 0.22% 94
2025
Q4
$2.95M Sell
562,065
-90,089
-14% -$356K 0.22% 81
2025
Q3
$2.82M Sell
652,154
-345,393
-35% -$621K 0.27% 66
2025
Q2
$1.05M Sell
997,547
-1,803,637
-64% -$2.16M 0.16% 80
2025
Q1
$3.61M Buy
2,801,184
+723,933
+35% +$1.14M 0.67% 44
2024
Q4
$5.19M Sell
2,077,251
-1,693,398
-45% -$6.03M 1.04% 22
2024
Q3
$15.3M Buy
+3,770,649
New +$14.1M 2.49% 10

Other funds holding ZURA

ADAR1 Capital Management's ZURA Position: Q2 2026 in Review

ADAR1 Capital Management increased its Zura Bio (ZURA) stake by 179% in Q2 2026, buying an estimated $5.38M and bringing the position to 1,759,295 shares worth $10.4M. The position accounts for 0.48% of the portfolio, ranked #51.

ADAR1 Capital Management first reported a position in ZURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $15.3M in Q3 2024. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • ADAR1 Capital Management held 1,759,295 shares of Zura Bio worth $10.4M as of Q2 2026.
  • ADAR1 Capital Management bought 1,128,892 Zura Bio shares in Q2 2026, an estimated $5.38M.
  • Zura Bio made up 0.48% of ADAR1 Capital Management's portfolio in Q2 2026, its #51 holding.
  • ADAR1 Capital Management first reported a position in Zura Bio in Q3 2024 and has held it in 8 quarters since.
  • ADAR1 Capital Management's Zura Bio position peaked at $15.3M in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.